Cargando…
Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: A case report and literature review
RATIONALE: The case report aims to discuss the clinical symptoms and treatment of encephalopathy caused by a novel syntaxin- binding protein 1 (STXBP1) genetic mutation. PATIENT CONCERNS: The patient, a girl, was born at 38+4 weeks of gestation. She had frequent spasm attacks accompanied by obvious...
Autores principales: | Liu, Shunli, Wang, Liyuan, Cai, Xiao Tang, Zhou, Hui, Yu, Dan, Wang, Zhiling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392729/ https://www.ncbi.nlm.nih.gov/pubmed/29718889 http://dx.doi.org/10.1097/MD.0000000000010663 |
Ejemplares similares
-
STXBP1-Related Developmental and Epileptic Encephalopathy
por: Wild, Brittani, et al.
Publicado: (2019) -
Stxbp1/Munc18-1 haploinsufficiency impairs inhibition and mediates key neurological features of STXBP1 encephalopathy
por: Chen, Wu, et al.
Publicado: (2020) -
STXBP6 Gene Mutation: A New Form of SNAREopathy Leads to Developmental Epileptic Encephalopathy
por: Vinci, Mirella, et al.
Publicado: (2023) -
Natural History Study of STXBP1-Developmental and Epileptic Encephalopathy Into Adulthood
por: Stamberger, Hannah, et al.
Publicado: (2022) -
Altered synaptic connectivity in an in vitro human model of STXBP1 encephalopathy
por: McLeod, Faye, et al.
Publicado: (2022)